Description

L-type calcium channel (Cav1.x) architecture and its modulation by select phytocannabinoids. L-type channels contribute to dendritic calcium signaling and synaptic plasticity in epileptogenic networks.

Figure 218

Diagram

Source Paper

Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Seizures and Epilepsy.

Pharmaceuticals (Basel, Switzerland) (2020)

PMID: 32751761

DOI: 10.3390/ph13080174

Cite This Figure

![Figure 218: L-type calcium channel (Cav1.x) architecture and its modulation by select phytocannabinoids. L-type channels contribute to dendritic calcium signaling and synaptic plasticity in epileptogenic networks.]()

> Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." *Pharmaceuticals (Basel, Switzerland)*, 2020. PMID: [32751761](https://pubmed.ncbi.nlm.nih.gov/32751761/)

<figure>
  <img src="" alt="L-type calcium channel (Cav1.x) architecture and its modulation by select phytocannabinoids. L-type channels contribute to dendritic calcium signaling and synaptic plasticity in epileptogenic networks." />
  <figcaption>Figure 218. L-type calcium channel (Cav1.x) architecture and its modulation by select phytocannabinoids. L-type channels contribute to dendritic calcium signaling and synaptic plasticity in epileptogenic networks.<br>  Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32751761/">32751761</a></figcaption>
</figure>

Related Evidence

CBD for Insomnia

Grade A · 103 studies